Review of NICE Technology Appraisal Guidance No 74 on the use of pre-hospital intravenous fluid therapy in trauma

Proposal to move guidance to the static list

The Institute has carried out a search for information relevant to this appraisal, and has found that to the best of its knowledge, no new evidence has been published that would have a material effect on the original guidance. Consequently we propose that the original guidance becomes static.

In order to be completely confident that this is appropriate, we are asking all original consultees, to inform us of any evidence which would suggest that a review would be beneficial. Please see the full list of the organisations we have contacted below.

Please note all comments received will be published on the Institute’s website when a decision has been taken.

9 February 2007

• Ambulance Service Association
• Baxter
• British Association for Immediate Care
• British Association for Emergency Medicine
• British Association of Paramedics
• British National Formulary
• British Trauma Society
• Department of Health
• Department of Public Health & Epidemiology, University of Birmingham
• Faculty of Pre-hospital Care
• Fresenius-Kabi
• Ivex Pharmaceuticals Ltd
• Joint Royal Colleges Ambulance Liaison Committee
• MacoPharma
• Ministry of Defence
• National Collaborating Centre for Health Technology Assessment (NCCHTA)
• NHS Confederation
• NHS Purchasing and Supply Agency
• NHS Quality Improvement Scotland
• Royal College of Anaesthetists
• Royal College of General Practitioners
• Royal College of Nursing
• Royal College of Paediatrics & Child Health
• Royal College of Physicians
• Royal College of Surgeons
• Royal Pharmaceutical Society
• The College of Emergency Medicine
• Welsh Assembly Government